These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy. Stentoft J; Nielsen JL; Hvidman LE Leukemia; 1994 Sep; 8(9):1585-8. PubMed ID: 8090035 [TBL] [Abstract][Full Text] [Related]
8. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group. Lo-Coco F; Avvisati G; Vignetti M; Breccia M; Gallo E; Rambaldi A; Paoloni F; Fioritoni G; Ferrara F; Specchia G; Cimino G; Diverio D; Borlenghi E; Martinelli G; Di Raimondo F; Di Bona E; Fazi P; Peta A; Bosi A; Carella AM; Fabbiano F; Pogliani EM; Petti MC; Amadori S; Mandelli F; Blood; 2010 Oct; 116(17):3171-9. PubMed ID: 20644121 [TBL] [Abstract][Full Text] [Related]
9. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis]. Xu SN; Chen JP; Liu JP; Xia Y Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733 [TBL] [Abstract][Full Text] [Related]
10. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial. Zhang L; Zou Y; Chen Y; Guo Y; Yang W; Chen X; Wang S; Liu X; Ruan M; Zhang J; Liu T; Liu F; Qi B; An W; Ren Y; Chang L; Zhu X BMC Cancer; 2018 Apr; 18(1):374. PubMed ID: 29615003 [TBL] [Abstract][Full Text] [Related]
11. All trans retinoic acid in acute promyelocytic leukemia. Degos L; Wang ZY Oncogene; 2001 Oct; 20(49):7140-5. PubMed ID: 11704842 [TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy. Stentoft J; Nielsen JL; Hvidman LE Leukemia; 1994; 8 Suppl 2():S77-80. PubMed ID: 7815844 [TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia. Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J Hematol Oncol; 2014 Mar; 32(1):40-6. PubMed ID: 23963734 [TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial. Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214 [TBL] [Abstract][Full Text] [Related]
15. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL). Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484 [TBL] [Abstract][Full Text] [Related]
16. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia. Dang CC; Guan YK; Lau NS; Chan SY J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594 [TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study]. Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Demidova IA; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Pivnik AV Ter Arkh; 1999; 71(7):20-4. PubMed ID: 10481862 [TBL] [Abstract][Full Text] [Related]